Article
SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding properties
2022-03-18
Abstract excerpt
The SARS-CoV-2 Omicron variant exhibits very high levels of transmission, pronounced resistance to authorized therapeutic human monoclonal antibodies and reduced sensitivity to vaccine-induced immunity. Here we describe P2G3, a human monoclonal antibody (mAb) isolated from a previously infected and vaccinated donor, which displays picomolar-range neutralizing activity against Omicron BA.1, BA.1.1, BA.2 and all oth...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- de66a6ab-8050-5dc7-a0fa-5320f5bd000b
- DOI
- 10.1101/2022.03.18.484873
